CA2755472C - Analogues de la temporine-sha et leurs utilisations - Google Patents

Analogues de la temporine-sha et leurs utilisations Download PDF

Info

Publication number
CA2755472C
CA2755472C CA2755472A CA2755472A CA2755472C CA 2755472 C CA2755472 C CA 2755472C CA 2755472 A CA2755472 A CA 2755472A CA 2755472 A CA2755472 A CA 2755472A CA 2755472 C CA2755472 C CA 2755472C
Authority
CA
Canada
Prior art keywords
peptide
leishmania
peptide according
nucleic acid
sha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2755472A
Other languages
English (en)
French (fr)
Other versions
CA2755472A1 (fr
Inventor
Ali Ladram
Denis Sereno
Feten Abbassi
Bruno Oury
Mohamed Amiche
Pierre Nicolas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique
Université Pierre et Marie Curie
Institut de Recherche pour le Développement
Original Assignee
Centre National de la Recherche Scientifique
Université Pierre et Marie Curie
Institut de Recherche pour le Développement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique, Université Pierre et Marie Curie, Institut de Recherche pour le Développement filed Critical Centre National de la Recherche Scientifique
Publication of CA2755472A1 publication Critical patent/CA2755472A1/fr
Application granted granted Critical
Publication of CA2755472C publication Critical patent/CA2755472C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2755472A 2009-03-19 2010-03-18 Analogues de la temporine-sha et leurs utilisations Expired - Fee Related CA2755472C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0951768A FR2943345B1 (fr) 2009-03-19 2009-03-19 Analogues de la temporine-sha et leurs utilisations
FR0951768 2009-03-19
PCT/FR2010/050487 WO2010106293A1 (fr) 2009-03-19 2010-03-18 Analogues de la temporine-sha et leurs utilisations

Publications (2)

Publication Number Publication Date
CA2755472A1 CA2755472A1 (fr) 2010-09-23
CA2755472C true CA2755472C (fr) 2017-11-21

Family

ID=41066385

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2755472A Expired - Fee Related CA2755472C (fr) 2009-03-19 2010-03-18 Analogues de la temporine-sha et leurs utilisations

Country Status (7)

Country Link
US (1) US9522942B2 (enExample)
EP (1) EP2408806A1 (enExample)
JP (1) JP5713211B2 (enExample)
BR (1) BRPI1009585A2 (enExample)
CA (1) CA2755472C (enExample)
FR (1) FR2943345B1 (enExample)
WO (1) WO2010106293A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3385343B2 (ja) 1996-12-26 2003-03-10 Ｎｔｎ株式会社 トリポード型等速自在継手
EP2853538A1 (en) * 2013-09-27 2015-04-01 Université Pierre et Marie Curie (Paris 6) Analogues of temporin-SHa and uses thereof
HRP20181705T1 (hr) * 2013-12-12 2018-12-28 Academisch Ziekenhuis Leiden H.O.D.N. Lumc Antimikrobni peptid i njegove uporabe
CN106117333A (zh) * 2016-07-06 2016-11-16 贵州师范大学 合江棘蛙皮肤抗菌肽及其编码序列的基因及原核表达
US10550155B2 (en) * 2018-03-27 2020-02-04 Farzana Shaheen Anticancer peptides
CA3221235A1 (en) 2021-06-11 2022-12-15 Ali Ladram Short antimicrobial peptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1194092A (en) * 1991-02-06 1992-09-07 Georgetown University Receptor blocking peptides of fibroblast growth factor receptor
US5916872A (en) * 1996-07-24 1999-06-29 Intrabiotics Pharmaceuticals, Inc. Cyclic peptides having broad spectrum antimicrobial activity

Also Published As

Publication number Publication date
WO2010106293A1 (fr) 2010-09-23
BRPI1009585A2 (pt) 2016-03-08
JP5713211B2 (ja) 2015-05-07
FR2943345A1 (fr) 2010-09-24
FR2943345B1 (fr) 2011-05-27
US20120005790A1 (en) 2012-01-05
US9522942B2 (en) 2016-12-20
JP2012520665A (ja) 2012-09-10
EP2408806A1 (fr) 2012-01-25
CA2755472A1 (fr) 2010-09-23

Similar Documents

Publication Publication Date Title
Sarkar et al. Antimicrobial peptides and proteins: from nature’s reservoir to the laboratory and beyond
Kosikowska et al. Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015)
Ladram et al. Antimicrobial peptides from frog skin: biodiversity and therapeutic promises
Kang et al. The therapeutic applications of antimicrobial peptides (AMPs): a patent review
EP3274472B1 (en) Antimicrobial peptides and methods of use thereof
US6288212B1 (en) Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor
JP6683601B2 (ja) 抗菌性ペプチド
Slocinska et al. Insects antiviral and anticancer peptides: new leads for the future?
KR20140039157A (ko) 항미생물성 융합 화합물 및 그의 용도
NO333073B1 (no) Cytotoksiske peptider modifisert med en eller flere ikke-genetiske, voluminose og/eller lipofile aminosyrer.
CA2755472A1 (fr) Analogues de la temporine-sha et leurs utilisations
DK3087092T3 (en) ANTIMICROBIAL PEPTID AND APPLICATIONS THEREOF
US5235038A (en) Deletion and substitution analogues of melittin peptide
ES2691323T3 (es) Análogos de temporina-SHa y usos de los mismos
Desriac et al. Antimicrobial peptides from fish
KR102146935B1 (ko) 광대노린재로부터 유래된 포에실로코리신-1 펩타이드, 이를 유효성분으로 포함하는 항균, 항진균 또는 항염증용 조성물
KR102026769B1 (ko) 장수풍뎅이 유충에서 유래한 알로미리나신-1 펩타이드, 이를 유효성분으로 포함하는 항균, 항진균 또는 항염증용 조성물
KR102146937B1 (ko) 왕사마귀로부터 유래된 테노데라신-1 펩타이드, 이를 유효성분으로 포함하는 항균, 항진균 또는 항염증용 조성물
KR101184008B1 (ko) 애기뿔소똥구리로부터 분리된 항진균 활성을 가지는 코프리신 펩타이드 및 그의 용도
FR2839311A1 (fr) Peptides antibacteriens, genes codant les peptides, vecteurs, organismes transformes, leurs preparations et les compositions les contenant
Zhou QUB-3170: A novel peptide with antimicrobial activities from the skin secretion of Phyllomedusa tarsius tarsiu
JP2024521385A (ja) 短鎖抗菌ペプチド
Liu Assessing bioactivity of a bioactive peptide from the defensive skin secretion of Odorrana schmackeri
FR2843591A1 (fr) Peptides antimicrobiens, polypeptides comprenant lesdits peptides, genes codant lesdits peptides, vecteurs, organismes transformes et compositions les contenant
FR3061178A1 (fr) Peptides antimicrobiens et leurs utilisations

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20150313

MKLA Lapsed

Effective date: 20200831